As part of the Future Talent Program at Merck, Amanda was a doctoral intern at the HPV Vaccine Outcomes team for the summer of 2024. Under the direction of Dr. Marcie Fisher-Borne, she supported the analysis and write up of a manuscript on implementation barriers and opportunities in pharmacy-based settings in the US and Canada. Dr. Fisher-Borne presented the preliminary findings at EUROGIN 2025.
After her internship ended, she stayed on with the HPV Vaccine Outcomes team at Merck as a consultant. She is currently supporting Dr. Xuedan You on a mixed-methods study to assess the disease burden and unmet needs among patients living with anogenital warts in China and Japan.
Amanda additionally supported the work of the Implementation Cross-Functional Team internally at Merck to launch of the SCALE framework and Merck-wide definition of implementation research to harmonize approaches to implementation science. This consisted of designing and drafting tools for markets to assess their current and upcoming evidence-based interventions to enhance HPV vaccination uptake.
Amanda J. Pierz, PhD, MSc 